Company: HURA
Filing Date: 2025-02-07
Form Type: S-4
Source: 0001193125-25-022803
Chunk: 875

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-02-07
Form: S-4
Chunk 875
---
LitigationA-31Section 4.10Available FundsA-31Section 4.11No Other Representations or WarrantiesA-31ARTICLE VCOVENANTSA-32Section 5.1Conduct of Business of the CompanyA-32Section 5.2Conduct of Parent and Merger Subs Pending the ClosingA-34Section 5.3No Control of Other Party’s BusinessA-35Section 5.4Solicitation of Transactions; RecommendationA-35Section 5.5Access to Information; ConfidentialityA-37Section 5.6Further Action; EffortsA-38Section 5.7Registration Statement; Proxy StatementA-38Section 5.8Takeover LawsA-40Section 5.9Notification of Certain MattersA-40Section 5.10Indemnification, Exculpation and InsuranceA-41Section 5.11Public AnnouncementsA-42Section 5.12Section 16 MattersA-42Section 5.13Listing of Parent Common StockA-43Section 5.14DeregistrationA-43Section 5.15Obligations of the Merger SubsA-43Section 5.16Stockholder LitigationA-43Section 5.17Company Stock PlansA-43Section 5.18Tax Treatment of MergersA-43Section 5.19Permitted Asset DispositionA-44ARTICLE VICONDITIONS PRECEDENTA-44Section 6.1Conditions to Each Party’s Obligation to Effect the MergersA-44Section 6.2Additional Conditions Precedent to Obligations of Parent and the Merger SubsA-45Section 6.3Additional Conditions Precedent to Obligations of the CompanyA-46ARTICLE VIITERMINATION, AMENDMENT AND WAIVERA-47Section 7.1TerminationA-47Section 7.2Effect of TerminationA-49Section 7.3Fees and ExpensesA-49Section 7.4Amendment or SupplementA-51Section 7.5Extension of Time; WaiverA-51A-ii

#### TABLE OF CONTENTS(Continued)PageARTICLE VIIIGENERAL PROVISIONSA-51Section 8.1Stockholders RepresentativeA-51Section 8.2Nonsurvival of Representations and WarrantiesA-53Section